Kanwal Raghav - Concepedia

Author

Kanwal Raghav

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Diane Liu, K Raghav, K. P. S. Raghav, K. Raghav, K.P. Raghav, K.P.S. Raghav, Kanwal P Raghav, Kanwal P S Raghav, Kanwal P. Raghav, Kanwal P. S. Raghav

528

Publications

8.6K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center National Cancer Center Hospital East University of Milan Guardant (United States)Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

About

Kanwal Raghav is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	30	2.1K
2	Health Sciences	11	11	417
3	Public Health	2	2	124
4	Cell Biology	2	2	45
5	Engineering	1	1	20

Kanwal Raghav

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study Funda Meric‐Bernstam, Herbert I. Hurwitz, Kanwal Raghav, The Lancet Oncology MedicineUpdated ReportPathologyColorectal CancerMultiple Basket Study	2019	543
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018 Jonathan M. Loree, Seerat Anand, Arvind Dasari, JAMA Oncology	2019	530
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers Rachna T. Shroff, Milind Javle, Lianchun Xiao, JAMA Oncology	2019	460
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial Salvatore Siena, Maria Di Bartolomeo, Kanwal Raghav, The Lancet Oncology OncologyGastrointestinal OncologyColorectal CancerPathologyCancer Treatment	2021	392
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406) Scott Kopetz, Katherine A. Guthrie, Van K. Morris, Journal of Clinical Oncology	2020	381
Clinical and molecular characterization of early‐onset colorectal cancer Alexandra N. Willauer, Yusha Liu, Allan Andresson Lima Pereira, Cancer	2019	341
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes Jonathan M. Loree, Allan Andresson Lima Pereira, Michael Lam, Clinical Cancer Research	2017	310
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial Ahmed O. Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao, The Lancet. Gastroenterology & hepatology	2022	241
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge Christine M. Parseghian, Jonathan M. Loree, Van K. Morris, Annals of Oncology	2018	228
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors Kaysia Ludford, Won Jin Ho, Jane V. Thomas, Journal of Clinical Oncology	2023	173

Page 1